Epac2: A molecular target for sulfonylurea-induced insulin release

Science Signaling

Volumn 2, Issue 85, 2009, Pages

  Hinke, Simon A ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETOHEXAMIDE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CHLORPROPAMIDE; EXCHANGE PROTEIN DIRECTLY ACTIVATED BY CYCLIC ADENOSINE MONOPHOSPHATE 2; GLIBENCLAMIDE; GLIPIZIDE; INSULIN; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT SUR1; PROTEIN; SULFONYLUREA DERIVATIVE; TOLBUTAMIDE; UNCLASSIFIED DRUG; VOLTAGE GATED CALCIUM CHANNEL;

CELLULAR DISTRIBUTION; DRUG MECHANISM; EXOCYTOSIS; HUMAN; INSULIN RELEASE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION;

MUS;

EID: 77953655041     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.285pe54     Document Type: Review

References (41)

1. U.S. Centers for Disease Control and Prevention, National Diabetes Fact Sheet: General Information and National Estimates on Diabetes in the United States, 2007 (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta, GA, 2008).
2. C.-L. Zhang, M. Katoh, T. Shibasaki, K. Minami, Y. Sunaga, H. Takahashi, N.Yokoi, M. Iwasaki, T. Miki, S. Seino, The cAMP sensor Epac2 is a direct target of antidiabetic sulfonylurea drugs. Science 325, 607-610 (2009).
3. K. Nagashima, A. Takahashi, H. Ikeda, A. Hamasaki, N. Kuwamura, Y. Yamada, Y. Seino, Sulfonylurea and non-sulfonylurea hypoglycemic agents: Pharmacological properties and tissue selectivity. Diabetes Res. Clin. Pract. 66 (suppl. 1), S75-S78 (2004).
4. S. A. Hinke, K. Hellemans, F. C. Schuit, Plasticity of the beta cell insulin secretory competence: Preparing the pancreatic beta cell for the next meal. J. Physiol. 558, 369-380 (2004).
5. L. Aguilar-Bryan, J. P. Clement IV, G. Gonzalez, K. Kunjilwar, A. Babenko, J. Bryan, Toward understanding the assembly and structure of KATP channels. Physiol. Rev. 78, 227-245 (1998).
6. L. Aguilar-Bryan, C.G. Nichols, S.W.Wechsler, J. P. Clement IV, A. E. Boyd III, G. González, H. Herrera-Sosa, K. Nguy, J. Bryan, D. A. Nelson, Cloning of the beta cell high-affinity sulfonylurea receptor: A regulator of insulin secretion. Science 268, 423-426 (1995).
7. N. Inagaki, T. Gonoi, J. P. Clement IV, N. Namba, J. Inazawa, G. Gonzalez, L. Aguilar-Bryan, S. Seino, J. Bryan, Reconstitution of IKATP: An inward rectifier subunit plus the sulfonylurea receptor. Science 270, 1166-1170 (1995).
8. C. G. Nichols, KATP channels as molecular sensors of cellular metabolism. Nature 440, 470-476 (2006).
9. L. Eliasson, X. Ma, E. Renstrom, S. Barg, P. O. Berggren, J. Galvanovskis, J. Gromada, X. Jing, I. Lundquist, A. Salehi, S. Sewing, P. Rorsman, SUR1 regulates PKA-independent cAMP-induced granule priming in mouse pancreatic Bcells. J. Gen. Physiol. 121, 181-197 (2003).
10. L. L. Baggio, D. J. Drucker, Biology of incretins: GLP-1 and GIP. Gastroenterology 132, 2131-2157 (2007).
11. S. A. Hinke, R. A. Pederson, C. H. McIntosh, Relative contribution of incretins to the glucose lowering effect of DP IV inhibitors in type 2 diabetes mellitus (T2DM). Adv. Exp. Med. Biol. 575, 119-133 (2006).
12. F. C. Schuit, D. G. Pipeleers, Regulation of adenosine 3′,5′-monophosphate levels in the pancreatic B cell. Endocrinology 117, 834-840 (1985).
13. S. A. Hinke, D. A. Canton, J. D. Scott, Control of insulin secretion by phosphorylation-dependent signalling networks. In Islets: Biology, Immunology, and Clinical Transplantation, F. R. Kandeel, Ed. (Springer, New York), in press.
14. H. Kawasaki, G. M. Springett, N. Mochizuki, S. Toki, M. Nakaya, M. Matsuda, D. E. Housman, A. M. Graybiel, A family of cAMP-binding proteins that directly activate Rap1. Science 282, 2275-2279 (1998).
15. J. L. Bos, Epac proteins: Multi-purpose cAMP targets. Trends Biochem. Sci. 31, 680-686 (2006).
16. N. Ozaki, T. Shibasaki, Y. Kashima, T. Miki, K. Takahashi, H. Ueno, Y. Sunaga, H. Yano, Y. Matsuura, T. Iwanaga, Y. Takai, S. Seino, cAMP-GEFII is a direct target of cAMP in regulated exocytosis. Nat. Cell Biol. 2, 805-811 (2000).
17. T. Shibasaki, H. Takahashi, T. Miki, Y. Sunaga, K. Matsumura, M.Yamanaka, C. Zhang, A. Tamamoto, T. Satoh, J. Miyazaki, S. Seino, Essential role of Epac2/Rap1 signaling in regulation of insulin granule dynamics by cAMP. Proc. Natl. Acad. Sci. U.S.A. 104, 19333-19338 (2007).
18. G. Kang, O. G. Chepurny, B. Malester, M. J. Rindler, H. Rehmann, J. L. Bos, F. Schwede, W. A. Coetzee, G. G. Holz, cAMP sensor Epac as a determinant of ATP-sensitive potassium channel activity in human pancreatic beta cells and rat INS- 1 cells. J. Physiol. 573, 595-609 (2006).
19. Y. Kashima, T. Miki, T. Shibasaki, N. Ozaki, M. Miyazaki, H. Yano, S. Seino, Critical role of cAMPGEFII- Rim2 complex in incretin-potentiated insulin secretion. J. Biol. Chem. 276, 46046-46053 (2001).
20. M. Niimura, T. Miki, T. Shibasaki, W. Fujimoto, T. Iwanaga, S. Seino, Critical role of the N-terminal cyclic AMP-binding domain of Epac2 in its subcellular localization and function. J. Cell. Physiol. 219, 652-658 (2009).
21. G. Kang, C. A. Leech, O. G. Chepurny, W. A. Coetzee, G. G. Holz, Role of the cAMP sensor Epac as a determinant of KATP channel ATP sensitivity in human pancreatic beta-cells and rat INS-1 cells. J. Physiol. 586, 1307-1319 (2008).
22. G. Kang, O. G. Chepurny, G. G. Holz, cAMP-regulated guanine nucleotide exchange factor II (Epac2) mediates Ca2+-induced Ca2+ release in INS-1 pancreatic beta-cells. J. Physiol. 536, 375-385 (2001).
23. G. G. Holz, G. Kang, M. Harbeck, M. W. Roe, O. G. Chepurny, Cell physiology of cAMP sensor Epac. J. Physiol. 577, 5-15 (2006).
24. G. Liu, S. M. Jacobo, N. Hilliard, G. H. Hockerman, Differential modulation of Cav1.2 and Cav1.3-mediated glucose-stimulated insulin secretion by cAMP in INS-1 cells: Distinct roles for exchange protein directly activated by cAMP 2 (Epac2) and protein kinase A. J. Pharmacol. Exp. Ther. 318, 152-160 (2006).
25. T. Shibasaki, Y. Sunaga, K. Fujimoto, Y. Kashima, S. Seino, Interaction of ATP sensor, cAMP sensor, Ca2+ sensor, and voltage-dependent Ca2+ channel in insulin granule exocytosis. J. Biol. Chem. 279, 7956-7961 (2004).
26. O. G. Chepurny, C. A. Leech, G. G. Kelley, I. Dzhura, E. Dzhura, X. Li, M. J. Rindler, F. Schwede, H. G. Genieser, G. G. Holz, Enhanced Rap1 activation and insulin secretagogue properties of an acetoxymethyl ester of an Epac-selective cyclic AMP analog in rat INS-1 cells: Studies with 8-pCPT-2'-O-Me-cAMP-AM. J. Biol. Chem. 284, 10728-10736 (2009).
27. L. R. Landa, Jr., M. Harbeck, K. Kaihara, O. Chepurny, K. Kitiphongspattana, O. Graf, V. O. Nikolaev, M. J. Lohse, G. G. Holz, M.W. Roe, Interplay of Ca2+ and cAMP signaling in the insulin-secreting MIN6 beta-cell line. J. Biol. Chem. 280, 31294-31302 (2005).
28. L. M. DiPilato, X. Cheng, J. Zhang, Fluorescent indicators of cAMP and Epac activation reveal differential dynamics of cAMP signaling within discrete subcellular compartments. Proc. Natl. Acad. Sci. U.S.A. 101, 16513-16518 (2004).
29. B. Ponsioen, J. Zhao, J. Riedl, F. Zwartkruis, G. van der Krogt, M. Zaccolo, W. H. Moolenaar, J. L. Bos, K. Jalink, Detecting cAMP-induced Epac activation by fluorescence resonance energy transfer: Epac as a novel cAMP indicator. EMBO Rep. 5, 1176-1180 (2004).
30. V. O. Nikolaev, M. Bunemann, L. Hein, A. Hannawacker, M. J. Lohse, Novel single chain cAMP sensors for receptor-induced signal propagation. J. Biol. Chem. 279, 37215-37218 (2004).
31. C. H. McIntosh, Dipeptidyl peptidase IV inhibitors and diabetes therapy. Front. Biosci. 13, 1753-1773 (2008).
32. A. Melander, G. Sartor, E. Wahlin, B. Schersten, P. O. Bitzen, Serum tolbutamide and chlorpropamide concentrations in patients with diabetes mellitus. BMJ 1, 142-144 (1978).
33. G. Sartor, A. Melander, B. Schersten, E. Wahlin-Boll, Serum glibenclamide in diabetic patients, and influence of food on the kinetics and effects of glibenclamide. Diabetologia 18, 17-22 (1980). (Pubitemid 10202722)
34. H. Rehmann, E. Arias-Palomo, M. A. Hadders, F. Schwede, O. Llorca, J. L. Bos, Structure of Epac2 in complex with a cyclic AMP analogue and RAP1B. Nature 455, 124-127 (2008).
35. M. A. Burke, R. K. Mutharasan, H. Ardehali, The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel. Circ. Res. 102, 164-176 (2008).
36. A. Björklund, J. Bondo Hansen, S. Falkmer, V. Grill, Openers of ATP-dependent K+-channels protect against a signal-transduction-linked and not freely reversible defect of insulin secretion in a rat islet transplantation model of Type 2 diabetes. Diabetologia 47, 885-891 (2004).
37. G. Kwon, K. L. Pappan, C. A. Marshall, J. E. Schaffer, M. L. McDaniel, cAMP dose-dependently prevents palmitate-induced apoptosis by both protein kinase A- and cAMP-guanine nucleotide exchange factor-dependent pathways in betacells. J. Biol. Chem. 279, 8938-8945 (2004).
38. F. Sawada, T. Inoguchi, H. Tsubouchi, S. Sasaki, M. Fujii, Y. Maeda, H. Morinaga, M. Nomura, K. Kobayashi, R. Takayanagi, Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta- cell line, MIN6. Metabolism 57, 1038-1045 (2008).
39. K. Maedler, R. D. Carr, D. Bosco, R. A. Zuellig, T. Berney, M. Y. Donath, Sulfonylurea induced betacell apoptosis in cultured human islets. J. Clin. Endocrinol. Metab. 90, 501-506 (2005).
40. B. X. Pan, F. Vautier, W. Ito, V. Y. Bolshakov, A. Morozov, Enhanced cortico-amygdala efficacy and suppressed fear in absence of Rap1. J. Neurosci. 28, 2089-2098 (2008).
41. I acknowledge fellowship support from the Canadian Diabetes Association and the Canadian Institutes of Health Research.